HARP

Harpoon Therapeutics, Inc. Common Stock

Delisted

HARP was delisted on the 8th of March, 2024.

84 hedge funds and large institutions have $196M invested in Harpoon Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$463K
Puts
$457K
Net Calls
Net Calls Change

Top Buyers

1 +$14.6M
2 +$4.91M
3 +$2.42M
4
O
OrbiMed
New York
+$2.21M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.81M

Top Sellers

1 -$9.41M
2 -$3.78M
3 -$2.64M
4
LCM
Laurion Capital Management
New York
-$2.42M
5
Two Sigma Investments
Two Sigma Investments
New York
-$2.18M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$100K
52
$99K
53
$97K
54
$90K
55
$85K
56
$76K
57
$75K
58
$72K
59
$59K
60
$44K
61
$43K
62
$36K
63
$34K
64
$34K
65
$32.7K
66
$22K
67
$21K
68
$17K
69
$15K
70
$13K
71
$8K
72
$7K
73
$7K
74
$6K
75
$5K